Sternotomy Pain

2

Review clinical trials related to Sternotomy Pain. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Early Screening of Chronic Post-sternotomy Pain Using the DN4-i Questionnaire

Chronic post-sternotomy pain (CPSP) is a common complication after cardiac surgery, with a reported prevalence between 30% and 50%. Several studies show that a significant proportion of patients experience persistent pain long after cardiac surgery, often with a neuropathic component. Internal mammary artery harvesting is known to cause intercostal nerve injury. Recent data suggest that early neuropathic pain, assessed using the DN4 score, may predict the chronicization of postoperative pain. This study is a prospective observationnal study to evaluate the association between early neuropathic pain (DN4-i ≥ 3/7 on postoperative day 5) and the occurrence of chronic post-sternotomy pain at 3 months in patients who underwent median sternotomy for coronary artery bypass grafting with internal mammary artery harvesting

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Institute Arnault Tzanck, FranceUpdated: May 22, 2026Locations: 1Duration: 6 Months
Eligibility criteria

Age ≥ 18 years [+2]

History of sternotomy [+4]

Status: Recruiting

Comparison of Erector Spinae Plane Block (ESPB) With the Combination of Superficial Parasternal Intercostal Plane Block (SPIPB) and Serratus Anterior Plane Block (SAPB) in the Management of Postoperative Sternotomy Pain in Patients Undergoing Cardiac Surgery Via Sternotomy

This study aims to compare the effectiveness of two regional anesthesia techniques in managing pain for participants undergoing cardiac surgery via sternotomy. The investigators will evaluate whether the Erector Spinae Plane Block (ESPB) or a combination of the Superficial Parasternal Intercostal Plane Block (SPIPB) and Serratus Anterior Plane Block (SAPB) provides better pain control and recovery outcomes.

Participants needed: 50
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Uludag UniversityUpdated: Mar 16, 2026Locations: 1
Eligibility criteria

Patients aged between 18 and 80 years. [+3]

Pregnancy or suspected pregnancy. [+8]